ImmunoGen, Inc. (IMGN) Reaches $4.88 After 4.00% Up Move, Hillhouse Capital Management LTD Has Decreased Ctrip Com Intl LTD (CTRP) Holding By $92.78 Million

May 30, 2017 - By Vivian Park

Hillhouse Capital Management Ltd decreased Ctrip Com Intl Ltd (CTRP) stake by 54.1% reported in 2016Q4 SEC filing. Hillhouse Capital Management Ltd sold 2.32 million shares as Ctrip Com Intl Ltd (CTRP)’s stock rose 23.06%. The Hillhouse Capital Management Ltd holds 1.97 million shares with $78.72M value, down from 4.29 million last quarter. Ctrip Com Intl Ltd now has $27.89 billion valuation. The stock declined 1.08% or $0.6 reaching $54.72 per share. About 248,754 shares traded. Ctrip.Com International Ltd (ADR) (NASDAQ:CTRP) has risen 31.59% since May 30, 2016 and is uptrending. It has outperformed by 14.89% the S&P500.

The stock of ImmunoGen, Inc. (NASDAQ:IMGN) is a huge mover today! About 470,273 shares traded. ImmunoGen, Inc. (NASDAQ:IMGN) has declined 3.49% since May 30, 2016 and is downtrending. It has underperformed by 20.19% the S&P500.The move comes after 5 months positive chart setup for the $406.14M company. It was reported on May, 30 by Barchart.com. We have $5.08 PT which if reached, will make NASDAQ:IMGN worth $16.25 million more.

Investors sentiment increased to 1.14 in Q4 2016. Its up 0.30, from 0.84 in 2016Q3. It is positive, as 20 investors sold ImmunoGen, Inc. shares while 37 reduced holdings. 21 funds opened positions while 44 raised stakes. 64.19 million shares or 12.81% less from 73.62 million shares in 2016Q3 were reported. Northeast Consultants holds 34,315 shares. Invesco Limited reported 0% in ImmunoGen, Inc. (NASDAQ:IMGN). Nationwide Fund reported 0% stake. Fifth Third Bank, Ohio-based fund reported 6,700 shares. Voya Inv Ltd Liability Corp has invested 0% in ImmunoGen, Inc. (NASDAQ:IMGN). Baystate Wealth Mgmt Limited Company holds 0% or 215 shares. Minnesota-based Walleye Trading Lc has invested 0% in ImmunoGen, Inc. (NASDAQ:IMGN). The Germany-based Deutsche Fincl Bank Ag has invested 0% in ImmunoGen, Inc. (NASDAQ:IMGN). Stifel Corporation owns 90,908 shares or 0% of their US portfolio. Hall Laurie J Trustee owns 560 shares. 32,880 are held by Tudor Corporation Et Al. Janney Montgomery Scott Ltd Liability Corporation reported 52,922 shares. 1.53M are held by State Street Corporation. Rhumbline Advisers has 106,169 shares. Commonwealth Equity Incorporated accumulated 13,468 shares.

Since December 15, 2016, it had 1 buying transaction, and 0 insider sales for $36,000 activity. $36,000 worth of stock was bought by Goldberg Mark Alan on Thursday, December 15.

ImmunoGen, Inc. is a clinical-stage biotechnology firm that develops targeted cancer therapeutics using its antibody-drug conjugate technology. The company has market cap of $406.14 million. The Firm is engaged in the discovery of monoclonal antibody anticancer therapeutics. It currently has negative earnings. An ADC with the Company’s technology comprises an antibody that binds to a target found on tumor cells conjugated to one of its anti-cancer agents as a payload to kill the tumor cell once the ADC has bound to its target.

Among 6 analysts covering Immunogen (NASDAQ:IMGN), 2 have Buy rating, 1 Sell and 3 Hold. Therefore 33% are positive. Immunogen had 8 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was upgraded by Jefferies on Wednesday, November 25 to “Buy”. The rating was maintained by Oppenheimer with “Outperform” on Wednesday, July 29. The stock of ImmunoGen, Inc. (NASDAQ:IMGN) has “Neutral” rating given on Monday, August 3 by Cantor Fitzgerald. The stock of ImmunoGen, Inc. (NASDAQ:IMGN) has “Underweight” rating given on Monday, September 21 by Morgan Stanley. RBC Capital Markets downgraded ImmunoGen, Inc. (NASDAQ:IMGN) on Friday, April 29 to “Sector Perform” rating. The firm earned “Market Perform” rating on Wednesday, October 28 by Leerink Swann. The stock of ImmunoGen, Inc. (NASDAQ:IMGN) earned “Market Perform” rating by Leerink Swann on Monday, May 2. RBC Capital Markets maintained ImmunoGen, Inc. (NASDAQ:IMGN) rating on Monday, July 27. RBC Capital Markets has “Outperform” rating and $20 target.

Hillhouse Capital Management Ltd increased Webmd Health Corp (NASDAQ:WBMD) stake by 100,792 shares to 554,717 valued at $27.50M in 2016Q4. It also upped Enstar Group Limited (NASDAQ:ESGR) stake by 1.41M shares and now owns 1.75 million shares. Proteostasis Therapeutics In was raised too.

Among 16 analysts covering Ctrip.com International Ltd. (NASDAQ:CTRP), 15 have Buy rating, 0 Sell and 1 Hold. Therefore 94% are positive. Ctrip.com International Ltd. had 33 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Wednesday, August 5 by Oppenheimer. The stock has “Buy” rating by Bank of America on Wednesday, October 7. HSBC downgraded the shares of CTRP in report on Tuesday, December 8 to “Hold” rating. The stock of Ctrip.Com International Ltd (ADR) (NASDAQ:CTRP) earned “Strong Buy” rating by Raymond James on Friday, November 13. The rating was upgraded by Stifel Nicolaus on Friday, August 28 to “Buy”. Bernstein initiated the stock with “Mkt Perform” rating in Wednesday, January 11 report. The firm has “Buy” rating by Piper Jaffray given on Tuesday, August 4. On Thursday, March 17 the stock rating was maintained by Brean Capital with “Buy”. Nomura initiated the shares of CTRP in report on Friday, January 22 with “Buy” rating. HSBC upgraded Ctrip.Com International Ltd (ADR) (NASDAQ:CTRP) rating on Friday, November 25. HSBC has “Buy” rating and $5 target.